| (Values in U.S. Thousands) | Dec, 2014 | Dec, 2013 | Dec, 2012 | Dec, 2011 | Dec, 2010 |
| Sales | 26,390 | 28,260 | 19,350 | 16,760 | 17,030 |
| Sales Growth | -6.62% | +46.05% | +15.45% | -1.59% | -7.45% |
| Net Income | 450 | 680 | -1,550 | -3,300 | -4,210 |
| Net Income Growth | -33.82% | +143.87% | +53.03% | +21.62% | +5.39% |
Erba Diagnostics Inc (ERB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
ERBA Diagnostics, Inc. develops, manufactures and markets diagnostic test kits, or assays, and automated systems primarily for autoimmune and infectious diseases. The main subsidiaries of the company include: Diamedix Corporation, Delta Biologicals S.r.l. and ImmunoVision, Inc. ERBA Diagnostics, Inc., formerly known as IVAX Diagnostics, Inc., is headquartered in Miami, Florida.